Skip to content
Recall Observatory FDA recall evidence

Device product

The Elecsys Anti-TSHR immunoassay is a three-step competitive immunoassay with streptavidin-coated microparticles and electrochemiluminescence detection. Patient serum sample is incubated with pretreatment reagent PT1 and the reconstituted PT2 containing a pre-formed immunocomplex of solubilized porcine TSH receptor (pTSHR) and biotinylated anti-pTSHR mouse monoclonal antibody.

Z-1009-2026

November 21, 2025

Class II

Product summary

Firm
Roche Diagnostics Operations, Inc.
Event
Event 98103
Status
Ongoing
Classification
Class II
Quantity
1300 cassettes
Official record key
device-enforcement:Z-1009-2026

Official wording

Reason: Issues identified: 1) Results vary by Instrument Platform; 2) Calibrator Lot-to-Lot Variability. Issues may lead to delayed or incorrect diagnosis, as well as delay of treatment or incorrect treatment.

Code information: 08496633190 lot 840183 exp. 02/26 08496633190 lot 874011 exp. 10/26 08496609190 lot 840177 exp. 05/26

Distribution pattern: US Nationwide distribution in the states of AZ, CA, FL, GA, IL, IN, ME, MI, MN, NC, NJ, NM, NY, OH, PA, PR, TN, TX, UT, WA, WV.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Issues identified: 1) Results vary by Instrument Platform; 2) Calibrator Lot-to-Lot Variability. Issues may lead to delayed or incorrect diagnosis, as well as delay of treatment or incorrect treatment.

Field note

Send feedback

We'll only use this to respond to your feedback.